Research & Development

Revolutionizing Cancer Care: In Vivo CAR-T Therapies Lead the Way
Research & Development Revolutionizing Cancer Care: In Vivo CAR-T Therapies Lead the Way

The landscape of cancer therapy is undergoing a transformative shift with the advent of in vivo CAR-T cell therapies. These innovative treatments promise to simplify, accelerate, and reduce the costs of cancer care, marking a significant departure from traditional ex vivo methods. This article

Can RNA Nanoparticles Revolutionize Advanced Prostate Cancer Therapy?
Research & Development Can RNA Nanoparticles Revolutionize Advanced Prostate Cancer Therapy?

The groundbreaking study conducted by researchers Yang Zhang, PhD, and Jinjun Shi, PhD, from Brigham and Women's Hospital, offers promising insights into the potential of RNA nanoparticles in treating advanced prostate cancer (PCa). Their research focuses on a dual-action strategy involving

Genetic Discovery Could Revolutionize Pan-Cancer Metastasis Treatments
Research & Development Genetic Discovery Could Revolutionize Pan-Cancer Metastasis Treatments

A groundbreaking discovery in cancer research has unveiled a "genetic signature" involving 177 genes that are shared across multiple cancer types, fundamentally challenging prior assumptions about the mechanisms driving cancer metastasis. These findings open new avenues for innovative

How Will CRH's Partnership with Cleveland Clinic Elevate Care Standards?
Research & Development How Will CRH's Partnership with Cleveland Clinic Elevate Care Standards?

Columbus Regional Health (CRH) has recently joined the Cleveland Clinic Connected program, an esteemed initiative aimed at enhancing healthcare quality by incorporating the expertise and best practices of Cleveland Clinic, a globally recognized healthcare institution. This partnership aims to

NXP800: A New Hope in Combatting Advanced Prostate Cancer Treatment Resistance
Research & Development NXP800: A New Hope in Combatting Advanced Prostate Cancer Treatment Resistance

The fight against advanced prostate cancer has taken a promising turn with the development of a new drug, NXP800. This innovative treatment aims to help patients for whom current therapies have become ineffective. By specifically targeting the heat shock factor 1 (HSF1) pathway, NXP800 addresses

Prioritizing Analytic Methods for Truncated Outcomes in Critical Care Trials
Research & Development Prioritizing Analytic Methods for Truncated Outcomes in Critical Care Trials

Navigating the complexities of critical care clinical trials, particularly when facing the issue of "truncation due to death," is crucial for obtaining unbiased, clear, and meaningful results. Patient-centered outcomes affected by death before they can be fully measured pose significant

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later